https://www.biospace.com/patient-selection Patient selection en-US Fri, 11 Sep 2026 12:19:36 GMT https://www.biospace.com/press-releases/eloxx-pharmaceuticals-announces-first-patients-dosed-in-phase-2b-exact-study-of-exaluren-in-nonsense-mutation-alport-syndrome Fri, 11 Sep 2026 12:19:36 GMT https://www.biospace.com/press-releases/eloxx-pharmaceuticals-announces-first-patients-dosed-in-phase-2b-exact-study-of-exaluren-in-nonsense-mutation-alport-syndrome